FDA Inspection 904964 — Bloodworks

Bloodworks — FEI 3023087

The FDA completed an inspection of Bloodworks on November 28, 2014 in Seattle, WA. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 1 citation was issued during this inspection. Product area: Biologics.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
November 28, 2014
Fiscal Year
2015
Product Type
Biologics
Project Area
Blood and Blood Products
Location
Seattle, WA (United States)

Citations

IDCFRDescription
8021 CFR 606.100(b)(1)Donor criteria